Altshuler David's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 3, 2022
- Accession no.
- 0001209191-22-006757
- Filed
- Feb 3, 2022
- Trade date
- Feb 1-2, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 11 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.17M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altshuler DavidCIK 0001550395 | Officer (EVP, Global Research and CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2022 | Common Stock | AGrant or awardAcquired | +8,166 | $0.00 | $0 | 41,755 | Direct | |
| Feb 1, 2022 | Common Stock | AGrant or awardAcquired | +11,628 | $0.00 | $0 | 53,383 | Direct | |
| Feb 1, 2022 | Common Stock | AGrant or awardAcquired | +12,314 | $0.00 | $0 | 65,697 | Direct | |
| Feb 2, 2022 | Common Stock | MOption exerciseAcquired | +4,660 | $86.52 | +$403,183.2 | 70,357 | Direct | |
| Feb 2, 2022 | Common Stock | SSaleDisposed | −500 | $247.73F5,F6 | −$123,865 | 69,857 | Direct | |
| Feb 2, 2022 | Common Stock | SSaleDisposed | −127 | $248.65F6,F7 | −$31,578.55 | 69,730 | Direct | |
| Feb 2, 2022 | Common Stock | SSaleDisposed | −754 | $249.97F6,F8 | −$188,477.38 | 68,976 | Direct | |
| Feb 2, 2022 | Common Stock | SSaleDisposed | −980 | $251.22F6,F9 | −$246,195.6 | 67,996 | Direct | |
| Feb 2, 2022 | Common Stock | SSaleDisposed | −900 | $252.10F6,F10 | −$226,890 | 67,096 | Direct | |
| Feb 2, 2022 | Common Stock | SSaleDisposed | −1,099 | $253.41F6,F11 | −$278,497.59 | 65,997 | Direct | |
| Feb 2, 2022 | Common Stock | SSaleDisposed | −300 | $254.46F6,F12 | −$76,338 | 65,697 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2022 | Common Stock | MOption exerciseDisposed | −4,660 | $86.52 | −$403,183.2 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F5
Open market sales reported on this line occurred at a weighted average price of $247.73 (range $247.35 to $248.34).
Referenced by the price of 1 transaction in Table I.
- F6
Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 7 transactions in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $248.65 (range $248.46 to $249.34).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $249.97 (range $249.61 to $250.33).
Referenced by the price of 1 transaction in Table I.
- F9
Open market sales reported on this line occurred at a weighted average price of $251.22 (range $250.71 to $251.70).
Referenced by the price of 1 transaction in Table I.
- F10
Open market sales reported on this line occurred at a weighted average price of $252.10 (range $251.75 to $252.72).
Referenced by the price of 1 transaction in Table I.
- F11
Open market sales reported on this line occurred at a weighted average price of $253.41 (range $253.05 to $253.99).
Referenced by the price of 1 transaction in Table I.
- F12
Open market sales reported on this line occurred at a weighted average price of $254.46 (range $254.34 to $254.58).
Referenced by the price of 1 transaction in Table I.
Remarks
Exhibit 24 - Power of Attorney